CARLSBAD, Calif.—SynergEyes, a maker of hybrid specialty contact lenses, has formed a partnership with the Brien Holden Vision Institute (BHVI), to deliver advanced, customized vision correction for myopes and presbyopes. An exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by BHVI, augmenting the SynergEyes presbyopic package by offering the latest designs on the hybrid contact lens platform. The tailored hybrid contact lens enabled through this technology will allow eyecare professionals to meet the needs of individual myopes and presbyopes, delivering “precise correction and a high degree of comfort,” according to a joint press release issued by SynergEyes and BHVI.

“SynergEyes seeks to improve the quality-of-life for people by delivering on the hybrid platform innovative lens designs that solve age-old problems in a new way,” said James Kirchner, OD, president and CEO of SynergEyes. “Working with a recognized worldwide leader like the Brien Holden Vision Institute, we plan to bring an extended depth-of-focus lens design onto the hybrid platform to the global market.

BHVI has developed new optical designs that incorporate an extended depth of focus (EDOF) to provide optimal visual performance from distance to near with minimal ghosting. The EDOF lens provides a series of smooth, non-monotonic, power variations across the optic zone to deliberately manipulate multiple higher-order aberrations. The idea is to achieve an extension in depth of focus that would facilitate a balanced visual performance designed to satisfy presbyopes with low, medium and high-add requirements, BHVI said.

“We are delighted to be partnering with SynergEyes to bring our novel EDOF designs in myopia and presbyopia management in specialty hybrid contact lenses and make them available to a broader market around the world,” said Prof. Kovin Naidoo, chief executive officer for BHVI. “This is especially important for myopia, as our mission is to slow the progression of myopia in all children to reduce their risk of permanent vision impairment and address a looming public health crises.”